======= SNX5 ======= == Gene Information == * **Official Symbol**: SNX5 * **Official Name**: sorting nexin 5 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=27131|27131]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q9Y5X3|Q9Y5X3]] * **Interactions**: [[https://thebiogrid.org/search.php?search=SNX5&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20SNX5|Open PubMed]] * **OMIM**: [[https://omim.org/entry/605937|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Involved in several stages of intracellular trafficking. Interacts with membranes containing phosphatidylinositol 3- phosphate (PtdIns(3P)) or phosphatidylinositol 3,4-bisphosphate (PtdIns(3,4)P2) (PubMed:15561769). Acts in part as component of the retromer membrane-deforming SNX-BAR subcomplex. The SNX-BAR retromer mediates retrograde transport of cargo proteins from endosomes to the trans-Golgi network (TGN) and is involved in endosome-to-plasma membrane transport for cargo protein recycling. The SNX-BAR subcomplex functions to deform the donor membrane into a tubular profile called endosome-to-TGN transport carrier (ETC) (Probable). Does not have in vitro vesicle-to-membrane remodeling activity (PubMed:23085988). Involved in retrograde transport of lysosomal enzyme receptor IGF2R (PubMed:17148574, PubMed:18596235). May function as link between endosomal transport vesicles and dynactin (Probable). Plays a role in the internalization of EGFR after EGF stimulation (Probable). Involved in EGFR endosomal sorting and degradation; the function involves PIP5K1C isoform 3 and is retromer-independent (PubMed:23602387). Together with PIP5K1C isoform 3 facilitates HGS interaction with ubiquitinated EGFR, which initiates EGFR sorting to intraluminal vesicles (ILVs) of the multivesicular body for subsequent lysosomal degradation (Probable). Involved in E-cadherin sorting and degradation; inhibits PIP5K1C isoform 3-mediated E-cadherin degradation (PubMed:24610942). Plays a role in macropinocytosis (PubMed:18854019, PubMed:21048941). {ECO:0000269|PubMed:18854019, ECO:0000269|PubMed:21048941, ECO:0000269|PubMed:24610942, ECO:0000303|PubMed:15561769, ECO:0000303|PubMed:19619496, ECO:0000303|PubMed:23085988}. |PX| |Vps5| |macropinocytic cup| |epidermal growth factor catabolic process| |retromer, tubulation complex| |tubular endosome| |extrinsic component of endosome membrane| |D1 dopamine receptor binding| |pinocytosis| |dynactin binding| |positive regulation of renal sodium excretion| |phosphatidylinositol-5-phosphate binding| |retromer complex| |regulation of renal sodium excretion| |regulation of excretion| |phagocytic cup| |phosphatidylinositol-3,5-bisphosphate binding| |phosphatidylinositol-4-phosphate binding| |regulation of renal system process| |negative regulation of blood pressure| |negative regulation of epidermal growth factor receptor signaling pathway| |negative regulation of ERBB signaling pathway| |brush border| |extrinsic component of cytoplasmic side of plasma membrane| |regulation of epidermal growth factor receptor signaling pathway| |phosphatidylinositol binding| |regulation of ERBB signaling pathway| |ruffle| |retrograde transport, endosome to Golgi| |cytoplasmic vesicle membrane| |cytosolic transport| |early endosome membrane| |regulation of macroautophagy| |regulation of blood pressure| |endosomal transport| |endosome| |cadherin binding| |regulation of autophagy| |blood circulation| |circulatory system process| |positive regulation of secretion| |protein heterodimerization activity| |endocytosis| |regulation of system process| |cellular protein catabolic process| |import into cell| |protein catabolic process| |regulation of secretion| |regulation of cellular catabolic process| |cellular macromolecule catabolic process| |positive regulation of transport| |regulation of catabolic process| |intracellular protein transport| |macromolecule catabolic process| |organonitrogen compound catabolic process| |negative regulation of signal transduction| |negative regulation of cell communication| |negative regulation of signaling| |protein transport| |intracellular transport| |peptide transport| |amide transport| |cellular protein localization| |cellular macromolecule localization| |establishment of protein localization| |negative regulation of response to stimulus| |positive regulation of multicellular organismal process| |organic substance catabolic process| |cellular catabolic process| |establishment of localization in cell| |nitrogen compound transport| |regulation of transport| |vesicle-mediated transport| |system process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp311|2-Methoxyestradiol 0.55 to 0.75μM on day4 R07 exp311]]|-1.76| |[[:results:exp302|35°C R06 exp302]]|-1.72| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 17649 * **Expression level (log2 read counts)**: 8.33 {{:chemogenomics:nalm6 dist.png?nolink |}}